Care Ratings has put ratings of various instruments of Punjab National Bank (PNB) under review. In an interview to CNBC-TV18, Rajesh Mokashi, MD & CEO of the company spoke at length about PNB ratings.

Issuance of bonds & CP likely to be higher in H2FY18: CARE Ratings

The bond issuances along with commercial paper (CP) has increased substantially in the first half as the credit offtake to the industry sector has been low in the banking system, Rajesh Mokashi, MD & CEO, CARE Ratings.

CARE Ratings signs MoU with Japan Credit Rating Agency

Dr Dogra, MD & CEO of Care Ratings, said that the alliance is particularly beneficial as JCR is among the 10 agencies recognised by the US Securities and Exchange Commission and also by few European countries.

See surveillance income growing at 8% in H2: CARE

The company's net profit fell 27.77 percent to Rs 37.85 crore during the second quarter ended September 30. The ratings agency had clocked a net profit of Rs 52.41 crore during the corresponding period of previous fiscal

Kalpyto's performance will surprise market this year: CARE

In an interview to CNBC-TV18, DR Dogra, MD & CEO, CARE Ratings, discusses the company's fourth quarter earnings and its future outlook.

CARE stake sale to aid CAR, awaiting Pipapav CDR nod: IDBI

After negotiating for bulk sale, IDBI offloaded 10 percent in CARE to LIC for Rs 421 crore. The bank's deputy MD BK Batra informed that the bank has strategic stake in various companies which are quite valuable today.

Post IDBI stake sale, LIC our largest shareholder: CARE

IDBI has recently sold 10 percent stake in CARE Ratings possibly to LIC which is now the largest shareholder.

CARE's rating upgrade to reduce 6% interest cost: Gravita

The rating upgrade will help reduce Gravita India‘s interest costs on borrowings by 6 percent, says company CEO Naveen Sharma.

Aban upgade on positive industry & co developments: CARE

P Sudhakar, additional general manager, CARE Rating, says the steps taken by the company to improve its balancesheet by raising equity aids the decision to upgrade the company.

May get Rs 600-700 cr for entire stake in CARE: IDBI Bank

BK Batra, DMD of IDBI Bank says the timing seems right to monetize a part or its entire stake in CARE. He believes the bank can get between Rs 600 crore and Rs 700 crore for its entire shareholding.

Eyeing inorganic growth ops; to focus on SMEs: CARE

CARE Ratings looks to strengthen its presence in the SME sector by opening additional 30-40 SME outlets, says company MD and CEO DR Dogra.

H2 will be better than H1; higher credit growth a plus:CARE

DR Dogra, MD and CEO, CARE Ratings says the company had a good quarter on stabilising credit growth. He adds that the second half earnings of the fiscal year will be better than the first half.

Corporate rating upgrades may continue going forward: CARE

For every downgrade there have been 1.25 upgrades in Q2FY15, says DR Dogra, MD & CEO of Care Ratings

Was looking for over Rs 900/shr for CARE stake: IDBI Bank

IDBI Bank was looking for over Rs 900 a share and the bids it received were below that price. IDBI Bank holds close to 17 percent in CARE and had put up its stake for sale

Hope to deliver better results in next 3 quarters: CARE

CARE would be conducting surveillance for more than 5,000 companies, which will certainly its topline in good order, says MD & CEO DR Dogra.

Expect lesser restructuring & provisioning in Q4: IDBI Bank

In an interview to CNBC-TV18, BK Batra, deputy managing director, IDBI Bank gives his views on the bank's Q3 performance. The bank's third quarter (October-December) net profit rose marginally just by 2% year-on-year.